FN2 Earnings Intelligence
AbbVie Inc. ratios (quarterly)
AbbVie Inc. (ABBV) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $7,257 | $5,175 | $6,467 | $5,629 | $9,391 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $14,460 | $13,343 | $15,423 | $15,776 | $15,002 | $16,787 | $17,342.4 |
| % Growth | - | - | - | - | - | 8.8% | 9.9% |
| Gross Profit | $10,248 | $9,341 | $11,077 | $10,472 | $10,784 | - | - |
| % Margin | 70.9% | 70.0% | 71.8% | 66.4% | 71.9% | - | - |
| EBITDA | $4,022 | $3,914 | $5,080 | $2,096 | $4,178 | - | - |
| % Margin | 27.8% | 29.3% | 32.9% | 13.3% | 27.8% | - | - |
| Net Income | $1,561 | $1,286 | $938 | $186 | $695 | - | - |
| % Margin | 10.8% | 9.6% | 6.1% | 1.2% | 4.6% | - | - |
| Diluted EPS | $0.88 | $0.72 | $0.52 | $0.10 | $0.39 | $3.60 | $3.86 |
| % Growth | - | - | - | - | - | 593.2% | 3,763.4% |
| Operating Cash Flow | - | $1,635 | - | - | $3,829 | - | - |
| CapEx | - | $235 | - | - | $265 | - | - |
| Free Cash Flow | - | $1,400 | - | - | $3,564 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $14,460 | $13,343 | $15,423 | $15,776 | $15,002 | $16,787 | $17,342.4 |
| Gross Profit | $10,248 | $9,341 | $11,077 | $10,472 | $10,784 | - | - |
| EBITDA | $4,022 | $3,914 | $5,080 | $2,096 | $4,178 | - | - |
| Net Income | $1,561 | $1,286 | $938 | $186 | $695 | - | - |
| Diluted EPS | $0.88 | $0.72 | $0.52 | $0.10 | $0.39 | $3.60 | $3.86 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7,257 | $5,175 | $6,467 | $5,629 | $9,391 |
| Short-term Debt | - | $1,593 | $5,556 | $3,790 | $0 |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $1,635 | - | - | $3,829 |
| Capital Expenditure | - | $235 | - | - | $265 |
| Free Cash Flow | - | $1,400 | - | - | $3,564 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 70.9% | 70.0% | 71.8% | 66.4% | 71.9% |
| EBITDA Margin | 27.8% | 29.3% | 32.9% | 13.3% | 27.8% |
| Net Margin | 10.8% | 9.6% | 6.1% | 1.2% | 4.6% |
| FCF Margin | - | 10.5% | - | - | 23.8% |
| Diluted EPS Growth | - | - | - | - | - |